Clinical Trial Update: Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of YZJ-1139 in insomnia disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• YZJ-1139

Snippet

Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Conditions: Insomnia Disorder | Phase 2 | Status: COMPLETED